Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Danaher Corporation (DHR) vs iShares iBoxx $ High Yield Corporate Bond ETF (HYG) Price & Performance

Danaher CorporationTrade
iShares iBoxx $ High Yield Corporate Bond ETFTrade

Price performance (Past 24H)

Key statistics

Danaher Corporation vs iShares iBoxx $ High Yield Corporate Bond ETF — how do they compare? Danaher Corporation trades at $219.8 (market cap $152.87B), while iShares iBoxx $ High Yield Corporate Bond ETF trades at $77.22 (market cap $17.89B). The key difference: Danaher Corporation is far larger — about 8.5× iShares iBoxx $ High Yield Corporate Bond ETF's market cap, and Danaher Corporation pays a 0.74% dividend while iShares iBoxx $ High Yield Corporate Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and iShares iBoxx $ High Yield Corporate Bond ETF for 60 Days on average.

DHRHYG
Market Cap
$152.87B$17.89B
Volume
5,228,69844,866,592
Sector
HealthFixed Income
52-Week High
$242.05$81.28
52-Week Low
$161.91$76.90
Typical Hold Time
69 Days60 Days
Enterprise Value
$175.08B—
Dividend Yield
0.74%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Danaher Corporation

Danaher (DHR) trades at $218.49, up 1.36% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst consensus is strongly bullish with a $230.31 price target, supported by institutional buying activity and a recent dividend announcement.

The outlook for DHR is positive, driven by earnings momentum and institutional confidence, but risks include elevated valuation multiples and competitive pressures in the healthcare sector. Investors should weigh the strong analyst support against potential margin compression and macroeconomic headwinds affecting capital spending.

iShares iBoxx $ High Yield Corporate Bond ETF

HYG trades at $77.205, showing minimal daily movement with a 0.03% gain. Technical indicators signal a bearish trend with moving averages and ADX pointing downward, though RSI suggests potential oversold conditions. The ETF maintains regular dividend distributions, with recent payouts ranging from $0.38 to $0.44. Market focus remains on high-yield bond performance amid rising Treasury yields and Federal Reserve policy uncertainty.

The outlook for HYG remains challenged by persistent bond market volatility and rising interest rates. While the fund's consistent dividend payments provide income support, the bearish technical setup and macroeconomic headwinds suggest continued pressure on high-yield corporate bonds. Investors face risks from credit quality deterioration and duration exposure in a rising rate environment.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DHR
3% Buy97% Sell
Avg holding period · 69 Days
HYG

No sentiment data available yet.

Top news

Latest headlines on both assets

About Danaher Corporation

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.

Read more on DHR →

About iShares iBoxx $ High Yield Corporate Bond ETF

HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.

Read more on HYG →